
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


Surgery Partners Inc (SGRY)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: SGRY (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $31
1 Year Target Price $31
8 | Strong Buy |
1 | Buy |
3 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -44.75% | Avg. Invested days 20 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.88B USD | Price to earnings Ratio - | 1Y Target Price 31 |
Price to earnings Ratio - | 1Y Target Price 31 | ||
Volume (30-day avg) 12 | Beta 1.82 | 52 Weeks Range 18.87 - 33.97 | Updated Date 08/15/2025 |
52 Weeks Range 18.87 - 33.97 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.43 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Earnings Date
Report Date 2025-08-05 | When - | Estimate 0.16 | Actual 0.17 |
Profitability
Profit Margin -5.57% | Operating Margin (TTM) 14.68% |
Management Effectiveness
Return on Assets (TTM) 3.92% | Return on Equity (TTM) 0.12% |
Valuation
Trailing PE - | Forward PE 28.33 | Enterprise Value 6513111725 | Price to Sales(TTM) 0.89 |
Enterprise Value 6513111725 | Price to Sales(TTM) 0.89 | ||
Enterprise Value to Revenue 2.01 | Enterprise Value to EBITDA 12.47 | Shares Outstanding 128209000 | Shares Floating 75492102 |
Shares Outstanding 128209000 | Shares Floating 75492102 | ||
Percent Insiders 1.45 | Percent Institutions 111.82 |
Upturn AI SWOT
Surgery Partners Inc

Company Overview
History and Background
Surgery Partners Inc. was founded in 2004. It has grown through acquisitions and partnerships to become a leading operator of surgical facilities and related healthcare services.
Core Business Areas
- Surgical Facility Services: Operates ambulatory surgery centers (ASCs) and surgical hospitals, providing a range of surgical procedures. It partners with physicians and hospitals.
- Ancillary Services: Provides a range of ancillary services, including anesthesia services, optical services, and physician services. These contribute to the overall value proposition.
Leadership and Structure
Wayne DeVeydt serves as the Executive Chairman of the Board. Tom Cowhey serves as Chief Executive Officer. The organizational structure includes regional and functional leadership roles overseeing operations, finance, and development.
Top Products and Market Share
Key Offerings
- Ambulatory Surgery Centers (ASCs): Provides surgical procedures in a lower-cost, convenient outpatient setting. Competitors include AmSurg (Envision Healthcare), United Surgical Partners International (USPI), and HCA Healthcare. Market share is in the 1-2% range nationally but higher regionally, and has been trending upward.
- Surgical Hospitals: Offers more complex surgical procedures in a hospital setting. Competitors include HCA Healthcare, Tenet Healthcare, and Community Health Systems.
Market Dynamics
Industry Overview
The ambulatory surgery center market is growing, driven by increasing demand for outpatient surgical procedures, technological advancements, and cost-containment pressures. There's a consolidation trend in the industry.
Positioning
Surgery Partners Inc. is positioned as a leading operator of surgical facilities, focusing on partnerships with physicians and hospitals. Its competitive advantage lies in its scale, network, and operational expertise.
Total Addressable Market (TAM)
The total addressable market for outpatient surgical procedures is estimated to be in the hundreds of billions of dollars annually. Surgery Partners Inc. is positioned to capture a larger share of this market through strategic acquisitions and organic growth.
Upturn SWOT Analysis
Strengths
- Established network of surgical facilities
- Strong relationships with physicians
- Operational expertise
- Focus on partnerships
- Favorable payer mix
Weaknesses
- High debt levels
- Integration risks associated with acquisitions
- Exposure to reimbursement rate changes
- Dependence on key physicians
- Competition in certain markets
Opportunities
- Increasing demand for outpatient surgical procedures
- Consolidation in the industry
- Expansion into new markets
- Growth in ancillary services
- Technological advancements
Threats
- Changes in healthcare regulations
- Reimbursement rate pressures
- Competition from other surgical facilities
- Economic downturn
- Rising operating costs
Competitors and Market Share
Key Competitors
- USPI
- AMSF
- HCA
Competitive Landscape
Surgery Partners Inc. faces competition from other large surgical facility operators and hospital systems. The company differentiates itself through its focus on partnerships and operational expertise.
Major Acquisitions
ASC of Baton Rouge
- Year: 2022
- Acquisition Price (USD millions): 16.5
- Strategic Rationale: Further expand market presence in key geographic area.
Aspen Healthcare Management
- Year: 2024
- Acquisition Price (USD millions): 85
- Strategic Rationale: Expands physician network in high-growth regions and offers new ancillary service offerings.
Growth Trajectory and Initiatives
Historical Growth: Surgery Partners Inc. has grown significantly through acquisitions and organic growth over the past decade.
Future Projections: Analysts project continued revenue growth for Surgery Partners Inc., driven by increasing demand for outpatient surgical procedures and the company's strategic initiatives.
Recent Initiatives: Recent strategic initiatives include acquisitions of surgical facilities, expansion into new markets, and investments in technology.
Summary
Surgery Partners Inc. is a growing company in the outpatient surgery market, driven by strategic acquisitions and partnerships. While it has shown strong revenue growth, its high debt levels and the competitive landscape pose challenges. The company's focus on physician alignment and expansion in high-growth markets are key strengths, but managing integration risks and reimbursement pressures is crucial for future success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Surgery Partners Inc. Investor Relations
- SEC Filings (10-K, 10-Q)
- Analyst Reports
- Industry Research Reports
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Investment decisions should be made based on individual due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Surgery Partners Inc
Exchange NASDAQ | Headquaters Brentwood, TN, United States | ||
IPO Launch date 2015-10-01 | CEO & Director Mr. J. Eric Evans | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 15000 | Website https://www.surgerypartners.com |
Full time employees 15000 | Website https://www.surgerypartners.com |
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; and ancillary services, such as multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.